Indefinite Delivery Contract HHSN268201600011I

Award Date 7/29/16
Last Date to Order 6/30/22
Ultimate Awardee
Not listed
Pricing Type
Order Dependent (IDV only)
Legislative Mandate
Not listed
National Interest Action
None
Award Type
Multiple
Primary Consortia Member
Not listed
Similar IDVs
The National Institutes of Health (NIH) Clinical Center awarded a single-award Indefinite Delivery Contract (IDC) to Miltenyi Biotec, Inc., a global biotechnology company, to provide proprietary CliniMACS cell isolation reagents and consumables. The $4.6 million contract has an initial base period through September 2025, with options to extend to 2027. This sole-source contract ensures the availability of FDA-approved, clinical-grade reagents and supplies compatible with the NIH's existing...
This indefinite delivery contract was awarded by the National Heart Lung and Blood Institute (NHLBI), a component of the U.S. Department of Health and Human Services, to Fujifilm Cellular Dynamics, Inc., a foreign-owned, for-profit manufacturer of induced pluripotent stem cell (iPSC)-derived human cell products. The contract supports the supply of a wide range of specialized cell types derived from iPSCs, such as cardiomyocytes, neurons, astrocytes, hepatocytes, and macrophages. These cell...
This indefinite delivery contract was awarded to Cellectis Bioresearch Inc. by the National Heart Lung and Blood Institute, a civilian federal agency, to provide professional support services. The contract is a multiple award, with a ceiling value of $6,984,000.00 and a period of performance through September 23, 2015. The contract aims to procure professional support services related to gene insertion and pluripotent stem cell research, as indicated by the parent master IDIQ contract title...
The U.S. Department of Health and Human Services (HHS), through the Office of the Assistant Secretary for Preparedness and Response (ASPR), has awarded a series of delivery order contracts to the American Type Culture Collection (ATCC), a nonprofit biological resource center, under an Indefinite Delivery Contract. These task orders, ranging in value from $103,046 to $103 million, task ATCC with providing a variety of services including the storage and distribution of biological samples,...
This indefinite delivery contract was awarded by the National Cancer Institute (NCI), a component of the U.S. Department of Health and Human Services, to Cedars-Sinai Medical Center, a nonprofit hospital and academic medical center located in Los Angeles. The $22,113 contract is for the recovery of tissue samples and data from various types of cancer to support the Cancer Genome Atlas (TCGA) program, which is part of the NCI's efforts related to the American Recovery and Reinvestment Act (ARRA)....
This indefinite delivery contract (IDC) was awarded by the National Cancer Institute (NCI), a civilian agency within the U.S. Department of Health and Human Services, to the University Health Network (UHN), a major Canadian academic health sciences center. The contract, with a total ceiling value of $114,818, is part of NCI's Cancer Genome Atlas (TCGA) program and involves the procurement of tissue samples and data from various types of cancer to support the program's objectives of evaluating...
The Department of Health and Human Services' National Center for Advancing Translational Sciences (NCATS) has issued a multiple-award Indefinite Delivery/Indefinite Quantity (IDIQ) contract valued at up to $49,885,703 to support Chemistry, Manufacturing, and Control (CMC) services for drug product development. The 7-year contract was awarded to Fisher Bioservices Inc.'s Clinical Trials Division, a subsidiary of Thermo Electron Corporation. The contract scope includes a wide range of CMC services...
The Department of Health and Human Services' National Institutes of Health (NIH) National Center for Advancing Translational Sciences (NCATS) has awarded a single-award indefinite delivery contract to Polypeptide Laboratories San Diego, LLC, a Contract Development & Manufacturing Organization (CDMO), to provide chemistry, manufacturing, and controls (CMC) services for the development of drug substances. This five-year, $49.7 million IDV contract, awarded without set-asides, supports NCATS'...
This is an Indefinite Delivery Contract (IDC) awarded by the National Cancer Institute (NCI), part of the Department of Health and Human Services, to the University of Pittsburgh - Of The Commonwealth System of Higher Education. The contract has a ceiling value of $507,219.52 and was awarded on March 24, 2010 with a final completion date of March 23, 2015. The purpose of this IDC is to recover tissue samples and data from various types of cancer for the Cancer Genome Atlas (TCGA) program,...
The U.S. Department of Health and Human Services (HHS) Office of the Assistant Secretary for Preparedness and Response (ASPR) has awarded a $20 billion Indefinite Delivery Contract to Advanced Technology International (ATI), a public service nonprofit, to establish and manage the Biopharmaceutical Manufacturing Preparedness Consortium (BIOMAP-Consortium). The consortium aims to build domestic manufacturing capabilities for medical countermeasures like vaccines, therapeutics, and personal...

- PRODUCTION ASSISTANCE FOR CELLULAR THERAPIES (PACT)- CELL PROCESSING FACILITIES

Posted 7/29/16, 12:00 AM